FDA Inspection 1255957 - Novo Nordisk Inc. - February 07, 2025

Record Details

This FDA Inspection record concerns Novo Nordisk Inc., with an inspection on February 7, 2025, issued by the New Jersey District Office, covering human drugs.

Company: Novo Nordisk Inc.
Inspection Date: February 7, 2025
Product Type: Human Drugs
Office: New Jersey District Office

Open in Dashboard

ID · db492566-9b2c-498b-81f8-e95e929b2d49

Violation Codes4

21 CFR 314.80(b)21 CFR 314.80(c)(1)(i)21 CFR 314.80(c)(1)(ii)21 CFR 314.80(c)(2)(ii)(B)

Full citation text and observation details available on the Dashboard.